Fast automated multi-criteria planning for HDR brachytherapy explored for prostate cancer.

Phys Med Biol

Erasmus MC Cancer Institute, Department of Radiation Oncology, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands. Author to whom correspondence should be addressed.

Published: October 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We developed a fast and fully-automated, multi-criteria treatment planning workflow for high dose rate brachytherapy (HDR-BT). In this workflow, the patient-CT with catheter reconstructions and dwell positions are imported from the clinical TPS into a novel system for automated dwell time optimisation. The optimised dwell times are then imported into the clinical TPS. The aims of automation were (1) planner-independent, enhanced plan quality, (2) short optimisation times. Our in-house developed system for fully automated, multi-criteria external beam radiotherapy (EBRT) treatment planning (Erasmus-iCycle) was adapted for optimisation of HDR-BT dose distributions. The investigations were performed with planning CT scans with catheter reconstructions and delineations of twenty-five low- and intermediate-risk prostate cancer patients who were previously treated in our center with [Formula: see text] Gy HDR-BT. Automatically generated plans (autoplans) were compared to the corresponding clinical plans. All evaluations were performed in the clinical TPS. The requested 95% tumour coverage was obtained for all autoplans, while this was only observed in 23/25 clinical plans. All autoplans showed a consistent reduction of the [Formula: see text] for the highest prioritised OAR, the urethra. The average and maximum reductions were 6.3%-point and 12.1%-point of the prescribed dose, respectively. In addition, conformality of the autoplans was higher. The autoplans had slightly smaller delivery times. Autoplanning took on average 4.6 s, including computation of the dose kernels.

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6560/ab44ffDOI Listing

Publication Analysis

Top Keywords

clinical tps
12
automated multi-criteria
8
prostate cancer
8
treatment planning
8
catheter reconstructions
8
imported clinical
8
[formula text]
8
plans autoplans
8
clinical plans
8
clinical
5

Similar Publications

Background: High-dose-rate (HDR) brachytherapy is essential in the treatment of locally advanced cervical cancer. While Iridium-192 (Ir-192) is commonly used, its short half-life imposes logistical and financial constraints, particularly in low- and middle-income countries (LMICs). Cobalt-60 (Co-60), with a longer half-life and lower operational costs, is a viable alternative.

View Article and Find Full Text PDF

Background: Difficult biliary cannulation is a key challenge in endoscopic retrograde cholangiopancreatography and a major risk factor for post-ERCP pancreatitis. When the pancreatic duct is unintentionally accessed, double guidewire (DGW) is the primary rescue strategy, while transpancreatic sphincterotomy (TPS) is an alternative. Previous evidence suggests that TPS may achieve higher cannulation success and lower PEP rates compared to DGW, though direct comparative data remain limited.

View Article and Find Full Text PDF

Background: Given that pathologists now frequently assess pathologic response following neoadjuvant or perioperative chemoimmunotherapy for NSCLC, we set up a multicentre study to evaluate the current practice of regression grading in Germany (Re-GraDE NSCLC).

Methods: 133 cases of NSCLC resection specimens following chemoimmunotherapy (IO) were collected from 9 high-volume lung cancer centres in Germany. Case characteristics were obtained from pathology reports/electronic medical records.

View Article and Find Full Text PDF

Introduction: Pembrolizumab is a standard first-line therapy for advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking actionable mutations. Data from lower-middle-income countries (LMICs) remain scarce.

Methods: From January 2019 to June 2024, we prospectively analyzed 78 a/mNSCLC patients receiving pembrolizumab-based first-line therapy.

View Article and Find Full Text PDF

Introduction: The accuracy of dose delivery in radiotherapy is paramount to maximize tumor control while minimizing damage to surrounding healthy tissues. This study presents a comprehensive analysis of gamma index validation in the treatment of cancerous tumors using Monte Carlo simulations with GAMOS and GATE codes on a Varian medical linear accelerator. By leveraging the MC method's robust statistical capabilities, the precision of dose distributions in external radiotherapy is aimed to be enhanced.

View Article and Find Full Text PDF